Descriptive Analysis of Surgeries in Patients With Multiple Osteochondromas

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorIstituto Ortopedico Rizzoli

About this trial

Multiple Osteochondromas (MO), also known as Multiple Cartilaginous Exostoses, is an autosomal dominant skeletal disorder with an incidence of approximately 1 in 50,000 in Western populations. Most cases are associated with pathogenic variants in the EXT1 and EXT2 genes, which lead to a systemic reduction of heparan sulfate, causing abnormalities in bone growth and other physiological processes.

Symptoms typically appear in childhood and include the development of bony protrusions often associated with pain due to compression of muscles and nerves. Patients are generally shorter than average and may experience dislocations, subluxations, reduced motor function, and skeletal deformities such as genu valgum, limb asymmetry, and scoliosis. The most severe complication is malignant transformation into chondrosarcoma, occurring in 0.5-5% of adult patients. Diagnosis is mainly based on imaging techniques (X-ray, CT, MRI, ultrasound) and is confirmed by the presence of at least two osteochondromas after excluding other conditions.

Following diagnosis, patients or their caregivers often raise questions regarding disease progression, the number and type of surgical interventions required, and differences between pediatric and adult surgical approaches. This retrospective observational cohort study aims to characterize the number and types of surgical procedures performed in MO patients at a European referral center, the Rizzoli Orthopaedic Institute.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients diagnosed with multiple osteochondromas who underwent surgery at the IOR between January 1, 2012, and February 28, 2025.

Patients of both sexes, regardless of age.

Disqualifiers

None

Trial population

Patients with multiple osteochondromas who underwent surgery at the Rizzoli Orthopedic Institute

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Surgery for osteochondromas

    Procedure/Surgery

    Surgeries for osteochondromas performed at the Rizzoli Orthopedic Institute

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number and type of surgeries for Multiple Osteochondromas

Time frame
3 years

Secondary outcomes

1

Conceptualization of a score based on osteochondromas location (bone site), severity (grading), and deformity/limitations (number and type)

The conceptualization of the score mentioned above will be explored as a secondary outcome.

Time frame
3 years
2

Descriptive analysis (mean, median, variance, standard deviation, interquartile range) of malignant transformations of osteochondromas

Descriptive metrics that will be used are mean, median, variance, standard deviation, interquartile range.

Time frame
3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.